What Are the Challenges and Future Directions for ALK Inhibitors?
One of the primary challenges with ALK inhibitors is the emergence of resistance, often due to additional mutations in the ALK gene. Researchers are actively working on next-generation inhibitors and combination therapies to address this issue. Ongoing studies aim to optimize treatment sequences and explore the use of ALK inhibitors in earlier stages of cancer and in other ALK-driven malignancies.
